Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Cell Reports|January 18, 2024
Partial loss of MCU mitigates pathology in vivo across a diverse range of neurodegenerative disease modelsMadeleine J Twyning, Roberta Tufi, Thomas P Gleeson, et al.
Nature Communications|October 16, 2014
Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutationsVinay K Godena, Nicholas Brookes-Hocking, Annekathrin Moller, et al.
Human Molecular Genetics|March 26, 2013
TRAP1 rescues PINK1 loss-of-function phenotypesLi Zhang, Peter Karsten, Sabine Hamm, et al.
Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)|May 25, 2021
Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectivesKehinde D Fasae, Amos O Abolaji, Tolulope R Faloye, et al.
Neurobiology of Disease|November 20, 2019
Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degenerationAndrea Loreto, Ciaran S Hill, Victoria L Hewitt, et al.
Scientific Reports|March 18, 2022
Protective capacity of carotenoid trans-astaxanthin in rotenone-induced toxicity in Drosophila melanogasterTemitope C Akinade, Oreoluwa O Babatunde, Adeola O Adedara, et al.
Life Science Alliance|June 21, 2024
Activation of the Keap1/Nrf2 pathway suppresses mitochondrial dysfunction, oxidative stress, and motor phenotypes in <i>C9orf72</i> ALS/FTD modelsWing Hei Au, Leonor Miller-Fleming, Alvaro Sanchez-Martinez, et al.
Human Molecular Genetics|December 9, 2010
PINK1 cleavage at position A103 by the mitochondrial protease PARLEmma Deas, Helene Plun-Favreau, Sonia Gandhi, et al.
Pageof 8